Nicox SA announced the formation of Nicox Glaucoma Clinical Advisory Board, composed of key clinical investigators and opinion leaders in the field, to support and guide the development of its innovative NO-donating compounds as potential intraocular pressure (IOP)-lowering drugs. Glaucoma Clinical Advisory Board members: Dr. Robert D. Fechtner, MD – Chairman. Robert D. Fechtner, MD, is Professor and Chair of the Department of Ophthalmology at SUNY Upstate Medical University in Syracuse, NY. Dr. Dr. Donald Budenz, MD MPH. Donald Budenz, MD, MPH, is the Kittner Family Distinguished Professor and Chairman, Department of Ophthalmology, UNC ChapelHill School of Medicine. He has authored 230 peer-reviewed articles, numerous book chapters, and a single-authored textbook entitled Atlas of Visual Fields. Dr. Steven L. Mansberger, MD MPH. Steven L. Mansberger, MD, MPH is Vice-Chair, Senior Scientist, and Director of Glaucoma Services and Ophthalmic Clinical Trials for the Devers Eye Institute in Portland, Oregon. He also is Clinical Professor of Ophthalmology at OregonHealth Science University. Helen DuBiner, PharmD. Helen DuBiner, PharmD has worked in clinical research for over 10 years and is also a part-time pharmacist. Helen DuBiner is with the Clayton Eye Center, where she is responsible for, among others, feasibility analysis of clinical studies, regulatory submissions and reports, setting and tracking budgets and training and oversight of research coordinators. She has managed over a hundred studies. Dr. Harvey DuBiner, MD. Dr. Harvey Dubiner is an ophthalmologist in Morrow, Georgia and has been with the Clayton Eye Center since 1988, and is affiliated with Southern Regional Medical Center. Dr. Tom Walters, MD. Dr. Tom Walters, MD is the most experienced eye surgeon in Central Texas. Dr. Walters has served as principal investigator for over 300 FDA-approved research clinical trials. He has authored and published research articles in every major ophthalmic journal, where he also performs peer-review for publications. He is active in assisting the development of new ophthalmic products and devices and presenting at national and international eye meetings.